On July 21, SCPKU was the site of a seminar entitled “Medical Big Data Application Assessment and Safeguards.” Co-sponsored by the Chinese Health Information Association (CHIA) and the China National Health Development Research Center of the People’s Republic of China (NHDRC), this event was the group’s second seminar focused on this topic which gathered over 80 participants including leaders from CHIA, NHDRC, local members of the Health and Family Planning Commission, and academic representatives from universities, medical institutes and pharmaceutical companies. The seminar concentrated on the fusion of medical big data and health care services, decision outcomes, as well as deployment by the State Council and National Health and Family Planning Commission of the People’s Republic of China (NHFPC).
Following NHDRC Director Wei Fu’s opening remarks, Xuefeng Ling, SCPKU Faculty Fellow, Principal Investigator of the Translational Medical Program at Stanford University and co-founder of HBI Solutions, gave a talk on the application of medical big data in decision support. Dr. Ling introduced big data based business intelligent solutions for health management platforms that hold electronic medical records as structured data. Big data based business intelligent solutions have been shown to yield better performance than traditional unstructured solutions in numerous cases including situational awareness, population approach, and risk information.
University of California-Riverside Bioengineering Associate Professor Jiayu Liao followed with a presentation on Chinese medicine and its contribution to medical big data. Dr. Liao cited the latest clinically validated immunosuppressant inspired by Chinese medicine which is cheaper and more effective than its predecessors. He also highlighted the first reported Non-peptide GLP-1R Agonist with in vivo efficacy and a new fluorescence resonance energy transfer technique, both of which are based on Chinese medicine.
Harvard Professor of Statistics and Director of Graduate Studies Jun Liu, West China Hospital Vice President and Professor Wei Zhang, and Taizhou Pharmaceutical High-Tech District Health Bureau Director Tao Zhang separately presented on medical big data applications in medical management and service, medical service evaluation and applications based on diagnosis related groups, and Taizhou’s demand and practices. NHFPC Associate Director and CHIA Chairman Xiaotao Jin and Chinese Academy of Chinese Medical Sciences (CACMS) and Academicians of Chinese Academy of Engineering (CAE) Dean Boli Zhang also presented.
Dr. Ling and Health and Development Center Professor Long Cheng closed the seminar with a discussion focused on early investigations into a medical big data application evaluation index system and an international medical big data human resources development cooperation plan.